Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (20 ops.)
Latest filing published 16 Oct 2026 for Beam Therapeutics Inc., €23k. Read the official filing
Filing timeline
BuySaleJohn M. Evans
Insider track record
Disclosed buys
0
Disclosed sells
20
Signal history
John M. Evans: trading record in brief
This profile gathers the share dealings of John M. Evans in Beam Therapeutics Inc., where the filings describe the role as chief executive. In total, 39 filings cover trades dated from 25 June 2021 to 16 October 2026.
On the market, this insider has only sold: 20 sales, €11.6M in total. The amount is not disclosed for 4 filings. Outside the open market, there are 3 share grants and 13 option exercises. 2026 to date brings no purchases and 9 sales.
On 16 October 2026 came the latest disclosure, an option exercise for €23k in Beam Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to John M. Evans
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations39 total
25,000 shares@ US$1.03Common StockSEC:0001193125-26-424421:0
25,000 shares@ US$23.566Common StockSEC:0001193125-26-424421:1
25,000 shares@ US$1.03Common StockSEC:0001193125-26-424421:2
25,000 shares@ US$23.9838Common StockSEC:0001193125-26-424421:3
18,663 sharesCommon StockSEC:0001193125-26-292526:0
6,337 sharesCommon StockSEC:0001193125-26-292526:1
13,421 sharesCommon StockSEC:0001193125-26-292526:2
11,579 sharesCommon StockSEC:0001193125-26-292526:3
25,000 sharesCommon StockSEC:0001193125-26-292526:4
23,100 sharesCommon StockSEC:0001193125-26-292526:5
1,900 sharesCommon StockSEC:0001193125-26-292526:6
30,078 shares@ US$24.585.9% of flowCommon StockSEC:0001193125-26-144086:0
90,000 shares0Common StockSEC:0001193125-26-138348:4
25,000 shares@ US$0.670.1% of flowCommon StockSEC:0001193125-26-138348:0
25,000 shares@ US$0.670.1% of flowCommon StockSEC:0001193125-26-138348:2
25,000 shares@ US$22.76344.6% of flowCommon StockSEC:0001193125-26-138348:3
25,000 shares@ US$22.36924.5% of flowCommon StockSEC:0001193125-26-138348:1
19,336 shares@ US$0.670.1% of flowCommon StockSEC:0001193125-26-033600:0
25,000 shares@ US$0.670.1% of flowCommon StockSEC:0001193125-25-230084:0
30,663 shares@ US$18.35064.8% of flowCommon StockSEC:0000950170-25-050857:0
30,000 shares@ US$0.670.2% of flowCommon StockSEC:0000950170-25-049297:0
77,500 shares0Common StockSEC:0000950170-25-049759:0
29,800 shares@ US$26.74597.1% of flowCommon StockSEC:0000950170-25-012304:0
60,000 shares@ US$24.600412.3% of flowCommon StockSEC:0000950170-24-111732:0
60,000 shares@ US$24.502612.7% of flowCommon StockSEC:0000950170-24-079065:0
25 of 39 declarations
